Summary:

• This blog summarizes the Ultra Low Field MRI Patient Care, Access, and Safety Considerations webinar in which Tobias Gilk and Robert Vart explore advancements in ultra-low-field MR imaging, highlighting safety for neurocritical care and benefits like improved turnaround times.
• Safety assessments with ultra-low-field MR imaging require specific knowledge for evaluating implants and devices.
• Implementing portable MR brain imaging technology can enhance efficiency, demonstrating substantial improvements in patient diagnosis and capacity management, notably in critical care scenarios​​.

Are you curious about the latest developments in magnetic resonance imaging (MRI) and the advantages of using portable ultra-low-field MR brain imaging systems for neurocritical patients? In a recent webinar hosted by Hyperfine, Inc., experts discussed safety considerations, differences between ultra-low-field, low-field, and high-field MR imaging, and the benefits of using a portable ultra-low-field MR brain imaging system for neurocritical patients.

During the webinar, radiology/MRI expert Tobias Gilk, MRSO (MRSC^_™), MRSE (MRSCC^_™), M. Arch., of Gilk Radiology Consultants, LLC, presented an overview of considerations for assessing safety for implants, devices, or foreign bodies, and general patient safety when dealing with ultra-low-field strengths. "It requires a little bit of additional knowledge and skill on behalf of the MR team, but with that knowledge and skill, you can and will be able to do assessments for these different implants, devices, and foreign bodies," Mr. Gilk shares.

In the second half of the webinar, Robert Vart, B.S. RT(R)(MR)(CT), MRSO(MRSCC^_™), a radiology program manager with BJC HealthCare, discusses some benefits of ultra-low-field MR imaging for patients, operational efficiencies for the MR departments and the hospital, and effective ways to implement the technology. "Some of the clinical benefits that we have found ... are patient conditions, timely procedures and diagnoses, capacity constraints, and staffing challenges."

"Within the first 30 days of use ... we saw 21.7% improvement [in turnaround time] in the ED," Mr. Vart shares. "Additionally, 21.9% improvement in neurology. But the one that's always really impactful for me is the ICU—64.1%."

Want to hear more? We invite you to view the webinar below and learn about ultra-low-field point-of-care MRI for the neurocritical patient.